Newly Published Data Supports Effectiveness of BIOTRONIK Neuro’s RESONANCE ™ Stimulationnews2023-10-05T13:15:59+00:00October 5th, 2023|Medical Device News Magazine|
Ariceum Therapeutics’ Targeted Radiopharmaceutical 177Lu-satoreotide Exhibits Promising Clinical Response and Good Tolerability Profile in Patients with Advanced Neuroendocrine Tumoursnews2023-09-28T11:39:29+00:00September 28th, 2023|Medical Device News Magazine|
New Hot Start Isothermal Mixes Boost Sensitivity, Specificity, and Speed of DNA Target Detectionnews2023-09-27T13:49:03+00:00September 27th, 2023|Medical Device News Magazine|
Branded Legacy Invests Heavily in Innovation and Growth with $540,000 Expansionnews2023-09-26T16:42:45+00:00September 26th, 2023|Medical Device News Magazine|
Cue Biopharma Completes Patient Enrollment in Ph1b Head & Neck Cancer Trialnews2023-09-26T15:41:15+00:00September 26th, 2023|Medical Device News Magazine|
Revvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to Curenews2023-09-26T11:41:34+00:00September 26th, 2023|Medical Device News Magazine|
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trialnews2023-09-22T11:02:16+00:00September 22nd, 2023|Medical Device News Magazine|
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of NASHnews2023-09-15T14:07:33+00:00September 15th, 2023|Medical Device News Magazine|
Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTechnews2023-09-12T14:50:41+00:00September 12th, 2023|Medical Device News Magazine|
Karger Publishers New Journal – Immune Systemnews2023-09-12T14:21:33+00:00September 12th, 2023|Medical Device News Magazine|